NSV Partners III LP, 10% Owner at Ventyx Biosciences, Inc. (VTYX), sold 545,090 shares at $29.01 ($15.8M) on 2022-12-01, disclosed to the SEC on 2022-12-02.
Open-market sale of $15.8M VTYX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.01 | 143,228 | $4.2M | 26.3% |
| 2 | $29.01 | 143,228 | $4.2M | 26.3% |
| 3 | $29.01 | 129,317 | $3.8M | 23.7% |
| 4 | $29.01 | 129,317 | $3.8M | 23.7% |
| Total | $29.01 avg | 545,090 | $15.8M | 100% |
| Filing → |
| VTYX | SELL | 2023-07-19 | $7.0M | — | Filing → |
| VTYX | SELL | 2023-07-06 | $10.5M | — | Filing → |
| VTYX | SELL | 2023-06-16 | $1.8M | — | Filing → |